Autolus Therapeutics
AUTL
$4.39
Share price
7.86%
Change (1 day)
48.81%
Change (1 year)
Categories
Operating Margin for Autolus Therapeutics (AUTL)
Operating Margin as of May 2024 (TTM): -2,080.38%
According to Autolus Therapeutics's latest financial reports and stock price the company's current Operating Margin is -2,080.38%. At the end of 2021 the company had an Operating Margin of -7,076.52%.
Operating Margin history for Autolus Therapeutics from 2019 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -7,076.52% | -89.82% |
| 2020 | -69,481.40% | 1323.28% |
| 2019 | -4,881.77% | 19.39% |
| 2018 | -4,089.05% | 195.62% |
| 2017 | -1,383.23% | 16.62% |
| 2016 | -1,186.14% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 0.00% | N/A | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.